Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States.

Eytan Stein,Jipan Xie,Emilie Duchesneau,Subrata Bhattacharyya,Umakanth Vudumula,Briana Ndife,Gaetano Bonifacio,Annie Guerin,Nanxin Li,George Joseph

PharmacoEconomics（2019）

Cited 15|Views14
No score
Abstract
This analysis suggests that midostaurin is a cost-effective treatment for adult patients with newly diagnosed FLT3-mutated AML, from a US third-party payer perspective.
More
Translated text
Key words
midostaurin,cost
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined